gepirone
Megjelenés
| Clinical data | |
|---|---|
| Trade names | Exxua |
| Other names | BMY-13805; MJ-13805; ORG-13011 |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 14–17% |
| Protein binding | 72% |
| Metabolism | CYP3A4 |
| Metabolites | 3'-OH-gepirone; 1-(2-Pyrimidinyl)piperazine |
| Elimination half-life | IR: 2–3 hours ER: 5 hours |
| Excretion | Urine: 81% |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C19H29N5O2 |
| Molar mass | 359.474 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Főnév
gepirone (tsz. gepirones)